Explore 3 Stock Ideas & Industry Insights Download Free Report

News

BK Technologies Q3 2026 Earnings Results Announced

BK Technologies Corporation filed a Form 8-K with the SEC on November 12, 2026, reporting its financial and operating results for the third quarter ended September 30, 2026, alongside a scheduled earnings conference call and webcast.

Aakashdeep | 12 November 2026

Southport Acquisition Corp. II Units Begin Separate Trading Nov. 16

Southport Acquisition Corp. II filed a Form 8-K on November 12, 2026, announcing that holders of its IPO units may elect to separately trade the Class A ordinary shares and warrants included in those units beginning November 16, 2026.

Anjali Anand | 12 November 2026

KBR Discloses Trinzic Investor Day on November 12, 2026

KBR, Inc. filed a Form 8-K on November 12, 2026, under Item 7.01 Regulation FD, announcing an investor day held that same date for Trinzic, Inc., currently a wholly owned subsidiary of KBR.

Shwetambri Chauhan | 12 November 2026

D-Wave Named Gartner Market Shaper in Quantum Computing

D-Wave Quantum Inc. filed a Form 8-K with the SEC on November 12, 2026, disclosing that the company has been recognized as a Market Shaper in the Gartner Emerging Market Quadrant for Quantum Computing - Established Vendors as of November 2026.

Shwetambri Chauhan | 12 November 2026

NIQ Global Intelligence Launches $150M Share Buyback

NIQ Global Intelligence plc filed a Form 8-K on November 12, 2026, disclosing both its financial results for the nine months ended September 30, 2026, and a newly approved share repurchase program of up to $150.0 million.

Nitish Kishor | 12 November 2026

BK Technologies Doubles Buyback to $10M on Nov 11, 2026

BK Technologies Corporation filed a Form 8-K on November 12, 2026, disclosing that its Board of Directors authorized a $5.0 million increase to its existing share repurchase program on November 11, 2026, bringing the total authorized amount to $10.0 million.

Aditi Sarkar | 12 November 2026

Alkermes Settles LYBALVI Patent Suit, Grants Teva 2039 License

Alkermes Public Limited Company filed a Form 8-K on November 12, 2026, disclosing that two of its wholly-owned indirect subsidiaries entered into a confidential settlement and license agreement with Teva Pharmaceuticals, Inc. on November 6, 2026, resolving a patent infringement lawsuit over all dosage …

Shwetambri Chauhan | 12 November 2026

StepStone COO Jose Fernandez Steps Down Nov. 11

StepStone Group Inc. filed a Form 8-K on November 12, 2026, disclosing that Co-Chief Operating Officer Jose A. Fernandez stepped down from his executive officer role effective November 11, 2026, and that Co-COO Jason P. Ment's title and responsibilities were simultaneously restructured.

Shwetambri Chauhan | 12 November 2026

Pelthos Therapeutics Amends S-8 to Cover 2026 Plan Rollover Shares

Pelthos Therapeutics Inc. filed a Post-Effective Amendment No. 1 to two previously filed Form S-8 registration statements on November 12, 2026, to register rollover shares under its newly approved 2026 Equity Incentive Plan.

Vinay Lochav | 12 November 2026

Pelthos Therapeutics Registers 500,000 Shares Under 2026 Equity Plan

Pelthos Therapeutics Inc. filed a Form S-8 registration statement with the U.S. Securities and Exchange Commission on November 12, 2026, to register 500,000 shares of common stock issuable under its newly adopted 2026 Equity Incentive Plan.

Nitish Kishor | 12 November 2026
Support

Hi! How can we help you today?

Loading…